-
Signature
-
/s/ James R. Gruber
-
Issuer symbol
-
ETON
-
Transactions as of
-
11 Dec 2025
-
Transactions value $
-
-$106,488
-
Form type
-
4
-
Filing time
-
12 Dec 2025, 16:56:45 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Krempa David |
Chief Business Officer |
C/O ETON PHARMACEUTICALS, INC., 21925 W. FIELD PARKWAY, SUITE 235, DEERPARK |
/s/ James R. Gruber |
12 Dec 2025 |
0001968254 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ETON |
Common Stock |
Tax liability |
-$106K |
-6.26K |
-0.98% |
$17.00 |
632K |
12 Dec 2025 |
Direct |
F1, F2, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ETON |
Restricted Stock Units |
Award |
$0 |
+5.3K |
+0.84% |
$0.00 |
638K |
11 Dec 2025 |
Common Stock |
5.3K |
|
Direct |
F4, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
The Reporting Person has authorized and designated the named person to file this Form 4 on the reporting person's behalf for indefinite duration.